Latest News
Jul 13, 2023
GLC Medical International BV (Belgium) Appoints Managing Director
Belgium, July 13, 2023 – GLC Medical International BV (GLCMI) is pleased to announce the appointment of Frank Van Gelder as Managing Director to drive Growth and Innovation in medical Diagnostics. With over three decades of experience in the healthcare sector, Mr. Van Gelder brings a wealth of knowledge and expertise to his new role.
Jul 13, 2023
GLC Medical(GLCM) Inc. Incorporates new Company in Belgium
Edmonton, AB, July 13, 2023 – GLC Medical (GLCM) Inc., a dynamic and innovative Canadian diagnostic company, announces its official incorporation and entry into the Belgian and European healthcare market to advance its GLCM platform technology. With a strong focus on advanced diagnostics and improving health outcomes, GLC Medical International BV (GLCMI) aims to revolutionize medical diagnostics through cutting-edge technology and scientific expertise.
Mar 2, 2021
GLCM Announce World's Fastest COVID-19 Virus Detection Insta-Test
GLC Medical (GLCM) Inc. is pleased to announce completion of development of the GLCM SARS-CoV-2 Insta-Test, delivering results in under 15 seconds, offering the world the fastest, easiest to use and most cost-effective solution to screen for COVID-19.
Jul 30, 2020
GLCM Announce Rapid Detection COVID-19 Test – Results in Seconds
Graphene Leaders Canada (GLC) Inc. together with subsidiary GLC Medical (GLCM) Inc. announce their development of a graphene-enhanced sensor for use in their COVID-19 Rapid Test delivering accurate and reliable results in seconds.
Looking for More?
We are expanding the global economy. The GLCM Biosensor Platform technology is available to license and will be a monumental product for future generations.
Modular integrations allow our technology to communicate with microelectronics. This can be utilized for real-time updates and relaying data to human resource managers and health associations.
GLC Medical is currently seeking strategic partners and welcomes all inquiries and discussions relating to the advancement of this breakthrough detection technology.
For more information, please email us at glcmsolutions@glcplus.com